National Science Board Urges Action to Sustain U.S. Leadership in Science and Engineering Research

Read more about the National Science Board's companion piece to Science and Engineering Indicators 2010, which includes recommendations for the growing world science and engineering capacity and an interactive tool that enables state data comparison.

Industry News

Biotech council: Biologics, innovation need protection from generics

President Obama and Congressional leaders have made a clear case for reform on the U.S. health care system, and we fully support a reform that would improve quality of care and controlling costs. President Obama and draft proposals in Congress have provided us with hope in these uncertain times, and we appreciate the strong initiative he and congressional leaders have demonstrated in attempting to reach consensus expeditiously. Members of the biotechnology industry — from early-stage startup companies to global biotech leaders — have significant concerns about one particular aspect of the health care reform effort, a pathway to biosimilars.